Drugs Based On Immune Factors Set To Double In Value By 2011 The discovery of the ubiquitous nature and influence of the human immune system on
health and disease has led to the emergence of a number of powerful
drugs that are bringing relief to patients afflicted with heretofore intractable conditions. These
drugs include Enbrel, Remicade, and Humira for the treatment of inflammatory autoimmune diseases, Herceptin for oncology, and Avonex and Betaseron for multiple sclerosis. Each of these
drugs had more than US $1 billion in sales in 2007.
Source: www.medicalnewstoday.comBellwether Industry's Confidence In UK Slumps - ABPI/CBI Survey, UK A key strategic industry for the UK, the pharmaceutical sector, has lost confidence in the country as a place to do business to an alarming degree, according to research published jointly by and the Association of the British Pharmaceutical Industry (ABPI) and the Confederation of British Industry (CBI). In a survey of more than 100 UK-based pharmaceutical companies, three-quarters had little confidence in the current environment.
Source: www.medicalnewstoday.comFree Drug Samples May Burden Patients' Pockets Following free drug sample receipt, patients who receive these samples have significantly higher out-of-pocket
prescription costs than those who don't, according to the first study to look at the out-of-pocket cost associated with free-sample use, published in the March 24, 2008, issue of Medical Care.Patients who never received samples had estimated out-of-pocket
prescription costs of $178 over six months.
Source: www.medicalnewstoday.com
# posted by Network @ 5:00 AM
